Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study - PubMed (original) (raw)
Comparative Study
. 2002 Dec;16(4):297-304.
doi: 10.1177/026988110201600403.
Affiliations
- PMID: 12503828
- DOI: 10.1177/026988110201600403
Comparative Study
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study
Chad E Beyer et al. J Psychopharmacol. 2002 Dec.
Abstract
The present study employed in-vivo microdialysis techniques in the freely moving rat to systematically compare the neurochemical effects of various antidepressant agents on extracellular concentrations of norepinephrine (NE) and serotonin (5-HT) in the frontal cortex. We found that acute administration of the tricyclic antidepressant, desipramine (3-30 mg/kg, s.c.) and the dual serotonin/norepinephrine reuptake inhibitor, venlafaxine (3-30 mg/kg, s.c.), produced dose-dependent and robust increases in cortical NE concentrations (498% and 403%, respectively). Conversely, acute injection of the selective serotonin reuptake inhibitors, fluoxetine (30 mg/kg, s.c.) and paroxetine (1-10 mg/kg, s.c.), did not alter forebrain NE concentrations. However, paroxetine did produce a significant increase in cortical NE concentrations (164%) when administered at 30 mg/kg. These changes in NE were not paralleled by 5-HT, which showed no increase following administration of desipramine, venlafaxine, paroxetine or fluoxetine. Combination treatment with the 5-HT1A receptor antagonist, WAY-100635 (0.3 mg/kg, s.c.), significantly enhanced extracellular 5-HT concentrations following venlafaxine (10 and 30 mg/kg), fluoxetine (30 mg/kg) and paroxetine (3-30 mg/kg). Alternatively, WAY-100635 produced no augmentation of the antidepressant-induced changes in extracellular NE. Collectively, these studies show that paroxetine, at low to intermediate doses, and fluoxetine are selective for 5-HT versus NE systems, whereas venlafaxine produces similar effects on both 5-HT and NE levels at the effective doses tested.
Similar articles
- Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA, Li P. Dawson LA, et al. J Neural Transm (Vienna). 2003 Jun;110(6):577-90. doi: 10.1007/s00702-003-0812-1. J Neural Transm (Vienna). 2003. PMID: 12768354 - Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
Dawson LA, Nguyen HQ, Geiger A. Dawson LA, et al. Neuropharmacology. 1999 Aug;38(8):1153-63. doi: 10.1016/s0028-3908(99)00052-0. Neuropharmacology. 1999. PMID: 10462128 - Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T, Umbers V, Gartside SE. Sharp T, et al. Br J Pharmacol. 1997 Jul;121(5):941-6. doi: 10.1038/sj.bjp.0701235. Br J Pharmacol. 1997. PMID: 9222551 Free PMC article. - Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C, Hyttel J. Sánchez C, et al. Cell Mol Neurobiol. 1999 Aug;19(4):467-89. doi: 10.1023/a:1006986824213. Cell Mol Neurobiol. 1999. PMID: 10379421 Review. - Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P. Blier P. J Clin Psychiatry. 2001;62 Suppl 15:12-7. J Clin Psychiatry. 2001. PMID: 11444761 Review.
Cited by
- Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain.
Fernández-Pastor B, Ortega JE, Meana JJ. Fernández-Pastor B, et al. Psychopharmacology (Berl). 2013 Sep;229(2):331-44. doi: 10.1007/s00213-013-3112-y. Epub 2013 May 2. Psychopharmacology (Berl). 2013. PMID: 23636303 - Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
Yamamoto S, Ohba H, Nishiyama S, Harada N, Kakiuchi T, Tsukada H, Domino EF. Yamamoto S, et al. Neuropsychopharmacology. 2013 Dec;38(13):2666-74. doi: 10.1038/npp.2013.176. Epub 2013 Jul 24. Neuropsychopharmacology. 2013. PMID: 23880871 Free PMC article. - Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. O'Leary OF, et al. Psychopharmacology (Berl). 2007 Jun;192(3):357-71. doi: 10.1007/s00213-007-0728-9. Epub 2007 Feb 21. Psychopharmacology (Berl). 2007. PMID: 17318507 - Antidepressant activity of curcumin: involvement of serotonin and dopamine system.
Kulkarni SK, Bhutani MK, Bishnoi M. Kulkarni SK, et al. Psychopharmacology (Berl). 2008 Dec;201(3):435-42. doi: 10.1007/s00213-008-1300-y. Epub 2008 Sep 3. Psychopharmacology (Berl). 2008. PMID: 18766332 - Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I. Cryan JF, et al. Proc Natl Acad Sci U S A. 2004 May 25;101(21):8186-91. doi: 10.1073/pnas.0401080101. Epub 2004 May 17. Proc Natl Acad Sci U S A. 2004. PMID: 15148402 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical